Literature DB >> 12174850

Profiling of acyl-CoA oxidase-deficient and peroxisome proliferator Wy14,643-treated mouse liver protein by surface-enhanced laser desorption/ionization ProteinChip Biology System.

Ruiyin Chu1, Weihua Zhang, Hanjo Lim, Anjana V Yeldandi, Chris Herring, Laura Brumfield, Janardan K Reddy, Matthew Davison.   

Abstract

Peroxisome proliferators induce hepatic peroxisome proliferation and hepatocellular carcinomas in rodents. These chemicals increase the expression of the peroxisomal beta-oxidation pathway and the cytochrome P-450 4A family, which metabolizes lipids, including fatty acids. Mice lacking fatty acyl-CoA oxidase (AOX-/-), the first enzyme of the peroxisomal beta-oxidation system, exhibit extensive microvesicular steatohepatitis, leading to hepatocellular regeneration and massive peroxisome proliferation. To investigate proteins involved in peroxisome proliferation, we adopted a novel surface-enhanced laser desorption/ionization (SELDI) ProteinChip technology to compare the protein profiles of control (wild-type), AOX-/-, and wild-type mice treated with peroxisome proliferator, Wy-14,643. The results indicated that the protein profiles of AOX-/- mice were similar to the wild-type mice treated with Wy14,643, but significantly different from the nontreated wild-type mice. Using four different ProteinChip Arrays, a total of 40 protein peaks showed more than twofold changes. Among these differentially expressed peaks, a downregulated peak was identified as the major urinary protein in both AOX-/- and Wyl4,643-treated mice by SELDI. The identification of MUP was further confirmed by two-dimensional electrophoresis and liquid chromatography coupled tandem mass spectrometry (LC-MS-MS). This SELDI method offers several technical advantages for detection of differentially expressed proteins, including ease and speed of screening, no need for chromatographic processing, and small sample size.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12174850      PMCID: PMC5977516          DOI: 10.3727/000000002783992460

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  33 in total

1.  ProFound: an expert system for protein identification using mass spectrometric peptide mapping information.

Authors:  W Zhang; B T Chait
Journal:  Anal Chem       Date:  2000-06-01       Impact factor: 6.986

2.  Profiling of amyloid beta peptide variants using SELDI Protein Chip arrays.

Authors:  H Davies; L Lomas; B Austen
Journal:  Biotechniques       Date:  1999-12       Impact factor: 1.993

3.  Changes in catalase, glutathione peroxidase and glutathione-S-transferase activities in the liver of newts exposed to 2-methyl-4-chlorophenoxyacetic acid (MCPA).

Authors:  A Santagostino; M Colleoni; E Arias; N Pacces Zaffaroni; T Zavanella
Journal:  Pharmacol Toxicol       Date:  1989-08

4.  Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha.

Authors:  B Ren; A P Thelen; J M Peters; F J Gonzalez; D B Jump
Journal:  J Biol Chem       Date:  1997-10-24       Impact factor: 5.157

5.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels.

Authors:  A Shevchenko; M Wilm; O Vorm; M Mann
Journal:  Anal Chem       Date:  1996-03-01       Impact factor: 6.986

Review 6.  Hepatocarcinogenesis of peroxisome proliferators.

Authors:  M S Rao; J K Reddy
Journal:  Ann N Y Acad Sci       Date:  1996-12-27       Impact factor: 5.691

7.  Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype.

Authors:  T Hashimoto; T Fujita; N Usuda; W Cook; C Qi; J M Peters; F J Gonzalez; A V Yeldandi; M S Rao; J K Reddy
Journal:  J Biol Chem       Date:  1999-07-02       Impact factor: 5.157

8.  Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease.

Authors:  Z Xiao; B L Adam; L H Cazares; M A Clements; J W Davis; P F Schellhammer; E A Dalmasso; G L Wright
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

9.  Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis.

Authors:  M Cherkaoui-Malki; K Meyer; W Q Cao; N Latruffe; A V Yeldandi; M S Rao; C A Bradfield; J K Reddy
Journal:  Gene Expr       Date:  2001

10.  Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism.

Authors:  C Y Fan; J Pan; N Usuda; A V Yeldandi; M S Rao; J K Reddy
Journal:  J Biol Chem       Date:  1998-06-19       Impact factor: 5.157

View more
  3 in total

1.  Protein profiling of mouse livers with peroxisome proliferator-activated receptor alpha activation.

Authors:  Ruiyin Chu; Hanjo Lim; Laura Brumfield; Hong Liu; Chris Herring; Peter Ulintz; Janardan K Reddy; Matthew Davison
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

Review 2.  Proteome Analyses of Hepatocellular Carcinoma.

Authors:  Dominik A Megger; Wael Naboulsi; Helmut E Meyer; Barbara Sitek
Journal:  J Clin Transl Hepatol       Date:  2014-03-15

Review 3.  Applications of SELDI-MS technology in oncology.

Authors:  L C Whelan; K A R Power; D T McDowell; J Kennedy; W M Gallagher
Journal:  J Cell Mol Med       Date:  2008-02-04       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.